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ABSTRACT

AMP-ACTIVATED PROTEIN KINASE KINASE ACTIVITY AND
PHOSPHORYLATION OF AMP-ACTIVATED PROTEIN
KINASE IN CONTRACTING MUSCLE OF
SEDENTARY AND ENDURANCETRAINED RATS

Denise Hurst
Department of Physiology and Developmental Biology
Master of Science

This study was designed to examine activity of AMP-activated protein kinase
kinase (AMPKK) and AMP-activated protein kinase (AMPK) in muscles from control
(C) and endurance trained (T) rats. Rats were trained 5 days/wk, 2 hr/d for 8 wks at a
final intensity of 32 m/min up a 15% grade with 30 second sprints at 52 m/min every 10
min. Gastrocnemius muscles were stimulated in situ in T and C rats for 5 min at
frequencies of 0.4/sec and 1/sec. Gastrocnemius LKB1 protein, a putative component of
the AMPKK complex (LKB1, STRAD, and MO25), increased approximately 2-fold in
response to training. Phosphorylation of AMPK determined by western blot was
increased at both stimulation rates in both control and trained rats. AMPK activity of

both the α1 and α2 isoforms (immunoprecipitates) also increased at both stimulation
rates in both C and T rats. AMPKK activity was strikingly lower in both resuspended
polyethylene glycol (PEG) precipitates and 1200 x g supernatant of the crude
homogenate of muscle extracts from the trained compared to control rats. AMPKK
activity did not increase in either T or C in response to electrical stimulation even
though phospho-AMPK did increase. Interestingly, AMPKK activity in the 1200 x g
supernatant of the crude homogenate actually decreased upon stimulation in the control
rats. These results suggest that AMPKK is activated during electrical stimulation by
mechanisms other than covalent modification. Possibilities include AMP-induced
optimization of the phosphorylation site on the target protein, contraction-induced
changes in undefined allosteric modulators, and contraction-induced association with
other proteins. (Study approved by the IACUC and supported by NIH RO1 AR41438.)
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INTRODUCTION
The AMP-activated protein kinase (AMPK) is a key monitor and regulator of
cellular energy status (20, 21, 40, 42). AMPK is activated by cellular stresses that
increase the cellular AMP: ATP ratio; this decreased cellular energy charge may come
as a result of hypoxia, pharmacological agents, low glucose, or muscle contraction (20,
21, 40, 42). When activated, AMPK phosphorylates multiple downstream targets to
activate catabolic pathways (ATP-replenishing) and inhibit anabolic pathways (ATPdepleting) (20, 21, 40, 42). AMPK phosphorylates targets involved in protein synthesis
(10, 45), glucose metabolism (17, 23), and lipid metabolism (2, 10, 27, 28, 39, 41).
AMPK is a heterotrimeric protein complex consisting of one each of the α, β,
and γ subunits (34). Each subunit exists as multiple isoforms, including α1, α2, β1, β2,
γ1, γ2, and γ3 (4, 9, 34). The β and γ subunits are noncatalytic and contain domains
involved in regulation and localization of AMPK (4, 9). The 63 kD α subunit is the
catalytic subunit and exists as two isoforms α1 and α2 (34). The α1 and α2 subunits both
contain a threonine at residue 172 with identical surrounding sequence indicating
similar phosphorylation and regulation by the upstream kinase(s) which are collectively
called AMP-activated protein kinase kinase (AMPKK) (15, 34, 43). Phosphorylation of
AMPK by AMPKK on Thr172 of the alpha subunit is necessary for full activation and
kinase activity; activation of AMPK may be as much as 50-fold due to phosphorylation
(15, 35, 43).
After a long search, LKB1 in complex with MO25 and STRAD has been
identified as a major upstream kinase in the AMPK cascade in liver (14, 27, 32, 44).
Recent studies using muscle-specific LKB1 knockout mice show decreases in basal and
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induced AMPK activation and phosphorylation, a reduction in mitochondrial oxidative
enzymes, decreased contraction-induced glucose uptake (22, 30, 31, 38).
Skeletal muscle contraction results in increased activation of AMPK and
phosphorylation of AMPK at Thr172 (7, 25, 26, 28). This increase in phospho-AMPK
suggests an increase in the activity of the upstream kinase, AMPKK. The mechanisms
that increase AMPKK activity as a result of muscle contraction are unclear. This study
was designed to determine if contraction-induced increases in AMPKK activity can be
detected in in vitro assays of AMPKK fractions isolated from gastrocnemius muscle and
if this activation is similar between trained and control rats at different rates of electrical
stimulation. Activating modifications of AMPKK that would be detected in in vitro
assays include covalent modifications (phosphorylation/dephosphorylation) and stable
association/disassociation with other proteins. If an increase in AMPKK activity is not
detected in in vitro assays, the activation may result from allosteric modulation (AMP,
phosphocreatine, glycogen, etc), transient association with other proteins, or changes in
cellular localization. It is also possible that AMPKK is constitutively active and
increased phosphorylation of AMPK as a result of contraction is due solely to allosteric
enhancement of AMPK as a substrate.
Several studies have noted that phosphorylation and activation of skeletal
muscle AMPK in response to muscle contraction is decreased after endurance-training
(7, 25). This attenuation could be due to several adaptations resulting from endurancetraining, including increased oxidative capacity and increased energy storage. It is also
possible that the reduction of AMPK responsiveness to contraction is due to direct
changes such as alterations in AMPK isoform expression (7, 25).
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We hypothesized that AMPKK activity would be increased in in vitro assays on
AMPKK fractions from electrically-stimulated gastrocnemius (as a result of covalent
modification or stable protein interactions). Additionally, we predicted that AMPKK
activation after stimulation would be lower in muscles from endurance-trained rats than
in their control counterparts since AMPK activation in response to muscle contraction
appears to be attenuated after endurance-training (7, 25).
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MATERIALS AND METHODS
Animal Care and Training Protocol. All animal procedures were approved by
the Institutional Animal Care and Use Committee of Brigham Young University. Male
Sprague-Dawley Rats (Sasco, Wilmington, MA) were housed singly in a temperature
controlled room (21° C) with a 12-hour light-dark cycle. Rats were assigned to either a
trained (T) or non-trained (NT) group. Trained rats ran on motor-driven rodent
treadmills at a 15 % grade 5 days/wk in a room cooled to 16° C. Training rats ran at
increasing intensity for at least eight weeks and were maintained at the highest intensity
for at least the final 2 weeks before sacrifice (total of 10-11 weeks). The initial training
intensity was two 45-min exercise bouts at 16 m/min. The final training intensity was a
single 120-min exercise bout at 32 m/min with 30 sec sprints at 53 m/min every 10 min.
Trained rats were provided with Harland Teklad rat chow ad libitum; non-trained rats
received the same diet in restricted amounts to maintain body weights similar to those
of the trained group. At the time of sacrifice, trained rats weighed 356 ± 13 g and nontrained rats weighed 353 ± 13 g (no significant difference, P < 0.05). A previous study
found untrained rats fed ad libitum and untrained food-restricted rats to have similar
AMPK activities (8).
In situ stimulation of the gastrocnemius muscle. On the day of sacrifice, rats
were anesthetized by intraperitoneal injection of sodium pentobarbital (50 mg/kg body
weight). Trained rats were anesthetized 18-24 hours after the last exercise bout. Rats
were maintained under anesthesia for at least 45 min before surgery to ensure any rise
in AMPK activity as a result of handling had subsided. The tibial nerve was exposed
surgically and attached to an electrode. Gastrocnemius muscles were electrically
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stimulated via the tibial nerve with 10 ms pulses at 4 V for 5 min at frequencies of .4
and 1/sec. After stimulation, muscles were rapidly removed, clamp-frozen between
stainless steel clamps at liquid nitrogen temperature, and stored at –95° C until analysis.
Tissue Homogenization. Muscles were ground to powder at liquid nitrogen
temperature using ceramic mortars and pestles. One part tissue was homogenized
thoroughly with 9 parts buffer using a glass homogenizer. Unless otherwise noted, the
following homogenization buffer was used: 50 mM Tris-HCl, 250 mM Mannitol, 50
mM NaF, 5mM Sodium Pyrophosphate, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100,
1 mM Dithiothreitol, 1 mM Benzamidine, 0.1 mM Phenylmethane sulfonyl fluoride
(PMSF), 5 μg/ml soybean trypsin inhibitor (SBTI), adjusted to pH 7.4 and cooled to
4°C. DTT, Benzamidine, PMSF, and SBTI were added immediately prior to tissue
homogenization. Tissue homogenates were then centrifuged at 1200 x g for 10 min to
remove connective tissue.
Citrate Synthase Activity Assay. Enzyme activity assays for Citrate Synthase
were done on preparations of 10% (w/v) tissue homogenates in Homogenization Buffer.
Homogenates underwent three freeze-thaw cycles prior to being assayed for citrate
synthase activity using the method of Srere (33).
AMPKK and AMPK Activity Assays. Enzyme activity assays for AMPKK were
done using preparations of 10% (w/v) tissue homogenates in Homogenization Buffer.
Tissue homogenates were centrifuged at 1200 x g for 10 min. To optimize for AMPKK
activity, polyethylene glycol (PEG 6000, Calbiochem) precipitations were done at cuts
of 6% and 10% (w/v) as previously described (15). Homogenates were then frozen at –
95˚ C until analysis. Both the 1200 x g supernatant and the PEG precipitates were

5

assayed for AMPKK activity. Activation of recombinant AMPK alpha-1312 subunit was
used to determine AMPKK activity of homogenates (12). The AMPK alpha-1312
subunit was prepared as previously described (36). Activation of AMPK alpha-1312 was
determined by radiolabel incorporation into AMARA peptide from ATPγP32. Tissue
homogenates (2 μl) were incubated (30˚ C) with AMPK alpha-1312 in storage buffer (4
μl) and AMPKK Assay Buffer (4 μl). Buffer formulations are described below. After
20 min., AMPK Assay Buffer was added (15 μl) and the reaction proceeded for an
additional 10 minutes. The reaction was then stopped by spotting the reaction mixture
(15 μl) on P81 filter papers (Whatman, Tewksbury, MA). Filter papers were washed in
100 ml 1% phosphoric acid (6 x 5 min), once with acetone, and then air dried. Filter
papers were transferred to glass liquid scintillation vials with 3 mls of Ecolite solution
(ICN; Irvine, CA) and counted for 10 min.
Activity measurements for both α1- and α2-AMPK were performed on
immunoprecipitates from the 1200 x g homogenate. Isoform-specific affinity-purified
antibodies (Affinity Bioreagents, Golden, CO) against TSPPDSFLDDHHLTR for α1
and MDDSAMHIPPGLKPH for α2 were used for immunoprecipitation of AMPK.
Immunoprecipitation and α1- and α2-AMPK activity measurements were done using the
method of Hardie et al (13). Our protocol varied in that immunoprecipitations were
overnight and the AMPK activity assay was on immunoprecipitates resuspended in the
buffer described previously (41).
AMPK alpha-1312 Storage Buffer. 50 mM Tris-HCl, 250 mM Mannitol, 1 mM
EDTA, 1 mM EGTA, 1 mM DTT, 0.02% Brij-35 (w/v), 10% glycerol (w/v), pH 7.4.

6

AMPKK Assay Buffer. 100 mM Hepes, 200 mM NaCl, 20 % glycerol (w/v), 2 mM
EDTA, 12.5 mM MgCl2, 0.5 mM AMP, 0.5 mM ATP, 2.0 mM DTT, pH 7.0.
AMPK Assay Buffer. 40 mM HEPES, 80 mM NaCl, 8% glycerol (w/v), 0.8 mM
EDTA, 0.8 mM DTT, 5 mM MgCl2, 0.2 mM AMP, 0.2 mM ATP, 0.33 mM AMRA
peptide, 0.133 μCi/μl ATPγP32, pH 7.0. (AMP, ATP, DTT, and ATPγP32 were added
just prior to use.)
Immunoblotting. Immunoblots were performed on the 1,200-g supernatant.
LKB1 immunoblots were performed on both the 1,200-g supernatant and the PEG
precipitate. Tissue homogenates were diluted in water and 4 x Laemmli’s buffer (1:2:1)
(24). Diluted homogenates (40 μl) were loaded into 50 μl well, Tris- HCl Ready Gels
(Bio-Rad, Hercules CA): 5% gels for ACC, and Phospho-ACC, 7.5% gels for AMPK
alpha-1 subunit, Phospho-AMPK, LKB1; 10% gels for AMPK gamma-3.
Homogenates were then separated by SDS-PAGE for 30-35 minutes.
Measurement of Acetyl-CoA Carboxylase Activity. For measurement of AcetylCoA Carboxylase (ACC) activity, frozen tissue was ground to powder at liquid nitrogen
temperature and homogenized in a buffer consisting of 200 mM mannitol, 50 mM NaF,
10 mM Tris, 1 mM EDTA, 10 mM β-mercaptoethanol, and 5 mg/L aprotinin, leupeptin,
and anti-trypsin (pH 7.5). ACC activity measurements were done on resuspended
ammonium sulfate precipitates and activity was determined at a citrate concentration of
0.5 mM using the method of Thampy et al (37) as previously described (41).
Measurement of lactate, phosphocreatine, ATP, creatine and glycogen. Frozen
gastrocnemius muscles were ground to powder under liquid nitrogen using a ceramic
mortar and pestle. Perchloric acid extracts were made from the frozen muscle powder
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(100 mg powder / ml 6% PCA) and used for analysis of lactate (11), phosphocreatine
(18), and ATP (18). Glycogen was measured as previously described (29). Muscle pH
was estimated using the method of Dudley et al (6).
Statistical analyses. Results are presented as means ± SE. Statistical
significance was determined by one-way ANOVA using Fisher’s LSD comparison of
data sets using the Number Cruncher Statistical Software (NCSS, Kaysville, UT). A
probability value of 0.05 was used to determine statistical significance in all analyses.
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RESULTS
As illustrated in Figure 1, Citrate Synthase activity was significantly higher (P <
0.001) in gastrocnemius muscles from trained (T) animals than those from control
animals. The increase in this mitochondrial enzyme confirms the efficacy of the
training protocol.
LKB1 protein content increased significantly (P < 0.05) in both as a result of
training (Figure 2). This increase in LKB1 was seen in western blots of both the 1200-g
homogenate and the PEG precipitates. AMPKK activity was determined in both the
1200-g supernatant of the crude homogenate and resuspended PEG precipitates from
the homogenate by measuring the increase in activity of the truncated alpha subunit of
AMPK. Even though LKB1 increased in response to endurance training, AMPKK
activity in both the 1200-g supernatant and the PEG precipitate was significantly (P <
0.05) lower in the muscles of trained animals than in control animals (Figure 3).
AMPKK activity did not increase in response to electrical stimulation in either control
or trained animals. In trained animals, stimulation of the gastrocnemius did not change
the AMPKK activity in either the 1200-g supernatant or the PEG precipitate (Figure 3).
In control animals, electrical stimulation at both .4/sec and 1/sec resulted in
significantly (P < 0.05) reduced AMPKK activity (compared to rest) in the 1200-g
supernatant of control animals (Figure 3). In the PEG precipitate from control animals,
AMPKK activity tended to be decreased after stimulation at 1/sec, but the difference
from rest was not significant (Figure 3).
It should be noted that the increase in LKB1 protein content in PEG precipitates
and the decrease in AMPKK activity in muscle homogenates from trained rats as
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compared to controls conflict with results from a previous study in our lab (36). In the
previous study using red quadriceps muscle from trained and control rats, there was no
difference in LKB1 protein content in PEG precipitates and no difference in AMPKK
activity between trained and control rats (36). The crude muscle homogenate in the
previous study did show increases in LKB1 protein. The homogenization buffer used in
the present study had detergent concentration of 1% compared to 0.5% detergent in the
previous study. The changes in extraction of LKB1 and AMPKK activity caused by
this change in detergent concentration have interesting implications for future study of
AMPKK complexes and localization.
The decrease of AMPKK activity in control rats and the stability of AMPKK
activity in trained rats after electrical stimulation are especially notable because AMPK
phosphorylation was significantly increased in the same muscle homogenates. Western
blot analysis of the 1200-g supernatant for phospho-AMPK (at Thr172) showed a
significant (P < 0.05) increase in phosphorylation as a result of stimulation at both
.4/sec and 1/sec; this increase was seen in both trained and control animals (Figure 4).
Although phospho-AMPK tended to be lower in trained than control at a stimulation
rate of 1/sec, the difference was not significant (P < 0.14). However, if just the two
1/sec groups (T and C) were compared to each other the difference was significant (P <
0.05). AMPK activity was determined on resuspended immunoprecipitates specific for
AMPKα1 and α2. The activity of both isoforms increased significantly (P < 0.05) in
response to electrical stimulation at .4/sec and 1/sec (Figure 5). There were no
significant differences between trained and control rats in AMPKα1 or α2 activity at any
stimulation rate.
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Acetyl-CoA Carboxylase (ACC) activity decreased significantly (P < 0.05) in
muscles from both trained and control rats as a result of electrical stimulation at both
.4/sec and 1/sec stimulation frequencies (Figure 6). ACC activity was not significantly
different between trained and control rats at any stimulation rate. This decrease in ACC
activity correlated with the increase in phosphorylation of ACC (by AMPK). Western
blots for phospho-ACC showed significant increases (P < 0.05) in phosphorylation at
both stimulation rates in trained and control rats (Figure 6). When compared to control
rats, trained rats had significantly more phospho-ACC at rest and when stimulated at
.4/sec but not at 1/sec (Figure 6).
Phosphocreatine (PCr) concentration decreased significantly (P < 0.05) in
stimulated gastrocnemius muscle of trained and control animals at both .4/sec and 1/sec
stimulation rates (Figure 7). At a stimulation rate of 1/sec, PCr in muscles from control
rats tended to be lower than trained but the difference was not significant. However, if
just the two 1/sec groups (T and C) were compared to each other the PCr was
significantly lower in control rats (P < 0.05). Glycogen concentration was significantly
higher in muscles from trained rats at rest and after electrical stimulation (Figure 7).
Trained animals were also more resistant to glycogen depletion; glycogen was
significantly depleted from rest only after stimulation at 1/sec. In control animals,
glycogen concentration decreased significantly at both stimulation rates (P < 0.05).
Lactic acid increased significantly (P < 0.05) in muscles of both trained and
control animals as a result of electrical stimulation (Figure 8). At a stimulation rate of
1/sec lactate was significantly lower in muscles of trained animals. The concentration
of ATP decreased significantly (P < 0.05) in both trained and control rats at the 1/sec
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stimulation rate; there were no significant differences in ATP concentration between
trained and controls at rest or after electrical stimulation (Figure 8).

12

DISCUSSION
This study reaffirms previous findings of increased activity and phosphorylation
of AMPK in response to muscle contraction (7, 25, 26, 28). This increase in phosphoAMPK suggests increased phosphorylation by the upstream kinase. In this study, we
hypothesized that AMPKK activity would be increased in muscle extracts from
electrically stimulated gastrocnemius muscle and that the increases in both AMPK and
AMPKK activities would be attenuated in endurance-trained animals as compared to
controls.
Several studies have noted that phosphorylation and activation of skeletal
muscle AMPK in response to muscle contraction is decreased after endurance-training
(7, 25). In this study, AMPK signaling was not attenuated in electrically-stimulated
muscles of trained rats as compared to control rats. AMPK activity and phosphoAMPK tended to be lower in muscle extracts from trained rats, but the differences
failed to reach significance. P-ACC was significantly lower at rest and a stimulation
rate of .4/sec but not at 1/sec (the rate where the most attenuation would be expected).
However, ACC activity was not significantly different between trained and control rats
at any stimulation frequency. Overall, no consistent evidence for blunting of AMPK
responses was seen in trained animals. One possible explanation for this is that rat
gastrocnemius muscles contain both IIA and IIB fibers. Type IIB fibers have lower
levels of mitochondrial enzymes and this may dilute the effects of training we would
expect to see in pure II A fibers.
There are several mechanisms by which AMPKK phosphorylation of AMPK
could be enhanced in response to muscle contraction. One possibility is covalent
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modification of AMPKK through phosphorylation or dephosphorylation by upstream
kinases or phosphatases as a result of muscle contraction. It is also possible that
contraction causes either association or disassociation of proteins that alter the AMPKK
activity. A third possibility is direct allosteric activation or disinhibition of AMPKK
by molecules or ions that are produced or degraded during contraction (PCr, AMP, H+,
glycogen, etc). A fourth option is that AMPKK may be sequestered to a different
cellular location in response to muscle contraction (cytosolic vs. nuclear, membranous,
or vesicular).
Lastly, it may be that AMPKK is constitutively in its active form and that the
increase in AMPK phosphorylation is solely due to substrate effects. Allosteric
modulators of AMPK (such as AMP, PCr, and glycogen) may increase exposure of
Thr172 for phosphorylation by AMPKK. Additionally, contraction may result in
reduced activity of protein phosphatases which dephosphorylate AMPK resulting in
lasting phosphorylation of AMPK. It is most likely that several of the above
mechanisms work in concert to increase the amount of phospho-AMPK in response to
muscle contraction.
We measured AMPKK activity in both PEG precipitates and crude homogenates
of electrically-stimulated rat muscle by measuring in vitro activation of the truncated
AMPKα subunit. AMPKK activity did not increase as a result of electrical stimulation
in gastrocnemius muscle of either control or trained rats, but phospho-AMPK did
increase in response to stimulation. In fact, AMPKK activity significantly decreased in
the 1200-g homogenates of control rats; this same trend was seen in the PEG precipitate
but it did not reach significance. Sakamoto et al found also found that in situ
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contraction of rat skeletal muscle (untrained) increased phospho-AMPK and AMPK
activity the activity of LKB1 (AMPKK) did not increase (30). If AMPKK were
activated covalently in response to muscle contraction we would expect the activation to
be stable enough for measurement in the muscle extracts. In addition, the
homogenization buffer used to process the muscles contained phosphatase inhibitors to
prevent dephosphorylation of proteins during tissue processing; this same processing
method successfully preserves AMPK activation as a result of phosphorylation. This
evidence suggests that AMPKK is not activated by phosphorylation/dephosphorylation
or some other covalent modification as a result of muscle contraction. The increase in
phosphorylation of AMPK as a result of muscle contraction must be due to some other
mechanism, such as those discussed previously.
Interestingly, Chen et al did see an increase in AMPKK activity in human
muscle after higher work-load exercise bouts (3). After exercise for 20 minutes at 59
and 79% of VO2 max, AMPKK activity was increased approximately 50% (3). This
apparent discrepancy from our results may indicate species-specific regulation of
AMPKK in response to muscle contraction.
LKB1 in complex with MO25 and STRAD has been identified as a major
upstream kinase in the AMPK cascade in liver (14, 27, 32, 44). A recent study in our
lab used muscle-specific (heart and skeletal) LKB1 knock-out mice to study the role of
LKB1 in the AMPK kinase cascade in skeletal muscle (38). In that study, electrical
stimulation of muscle increased phospho-AMPK and AMPK activity in wild type mice
but LKB1 knockout mice did not show similar increases. In addition, muscles isolated
from LKB1 knockout mice at rest had lower phospho-AMPK and phospho-ACC than
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their wild-type counterparts (38). This report confirmed the results of other LKB1
knock-out studies. Sakamoto et al also reported the muscle-specific LKB1 knockouts
had greatly reduced basal AMPKα2 activity and that this activity was not increased in
response to AICAR, phenformin, or muscle contraction—all of which are wellestablished activators of AMPK (31). AICAR and contraction-induced glucose uptake
was also diminished in LKB1 knockouts (22, 31). These and other studies provide
convincing evidence that LKB1 is a part of the major upstream kinase in the AMPK
signaling pathway in skeletal muscle.
In the current study, LKB1 protein content was significantly increased in
response to training; this increase was ~2-fold in 1200-g homogenates of gastrocnemius
muscle. This finding is especially interesting since AMPKK activity was significantly
lower in muscle extracts from trained rats as compared to controls; in PEG precipitates
activity decreased 73% in response to endurance training. Since LKB1 has been
identified as a major AMPKK in skeletal muscle, we would expect increases in LKB1
protein to correspond to increased AMPKK activity. In another study in our lab,
endurance training significantly increased LKB1 and MO25 protein content in red
quadriceps but also did not increase AMPKK activity (36). STRAD mRNA did not
increase in response to training; STRAD protein levels could not be evaluated. Since
STRAD is necessary for the kinase activity of LKB1/MO5/STRAD complexes (14, 15)
decreased expression or increased degradation of STRAD protein as a result of training
could result in decreased AMPKK activity. More research on the effect of endurancetraining on STRAD is necessary to determine the plausibility of this hypothesis.
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In this study LKB1 protein was significantly increased in both the 1200-g
homogenate and the PEG precipitates. Also, AMPKK activity was decreased in trained
rats compared to controls. In a previous study in our lab using red quadriceps muscle
from trained and control rats, there was no difference in LKB1 protein content in PEG
precipitates and no difference in AMPKK activity between trained and control rats (36).
Homogenates in the previous study were centrifuged at 700 x g while the current study
used a 1200 x g centrifugation. The homogenization buffer used in the present study
had detergent concentration of 1% compared to 0.5% detergent in the previous study.
Changes in detected LKB1 protein content and AMPKK activity as a result of a change
in detergent concentration or centrifugation speed may indicate differential regulation of
AMPKK resulting from alterations in protein complexing/binding partners or changes
in cellular localization.
There is some evidence that much of the increased AMPKK phosphorylation
of AMPK as a result of energy challenges may be due to substrate effects. For example,
AMP is a major activator of the cascade and has been shown to activate AMPK via 3
distinct mechanisms: direct allosteric activation of kinase activity, allosterically making
it a better substrate for AMPKK phosphorylation, and inhibiting dephosphorylation of
Thr172 by protein phosphatases (5, 15, 16, 20). While early reports indicated AMP
may also directly activate AMPKK (15, 16) this does not appear to be the case (21). In
addition, a recent study showed that phenformin and AICAR treatment of skeletal
muscle increased AMPK phosphorylation and activity but did not increase LKB1
(AMPKK) activity indicating effects at the substrate level (30).
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In summary, LKB1 protein content increased in gastrocnemius muscle as a
result of endurance training but AMPKK activity decreased. The functional
significance of increased LKB1 protein is unknown. Electrical stimulation of
gastrocnemius muscle increased phosphorylation and activity of AMPK but did not
increase AMPKK activity in trained or control rats. These data suggest that
contraction-induced activation of AMPKK is not a result of covalent modification.
Activation may result from direct allosteric enhancement, changes in protein
associations, or various enhancements of AMPK as a substrate for a constitutivelyactive AMPKK. In addition, it is possible that the blunted phosphorylation and
activation of AMPK seen in other studies of trained animals may be a result of
significantly reduced AMPKK activity.
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FIGURE LEGENDS
Figure 1. Citrate Synthase activity in gastrocnemius muscle of control and trained rats.
Values are means ± SEM, n = 7. *Significantly different from control rats, P < 0.001.
Figure 2. LKB1 immunoblots in gastrocnemius muscle of control (C) and trained (T)
rats. Values are means ± SEM, n = 9. *Significantly different from control, P < 0.05.
Figure 3. AMP-activated protein kinase kinase (AMPKK) activity in resting and
electrically stimulated gastrocnemius muscle from control and trained rats. Top:
AMPKK activity in the 1200-g supernatant. Bottom: AMPKK activity in resuspended
PEG precipitates. Values are means ± SEM, n = 7–9. *Significantly different from
control at the same stimulation rate, P < 0.05. †Significantly different from Rest in
control animals, P < 0.05.
Figure 4. Phospho-AMPK (at Thr172) immunoblots in resting and electrically
stimulated gastrocnemius muscles from control and trained rats. Values are means ±
SEM, n = 9. *Significantly different from rest, P < 0.05.
Figure 5. Activity of α1 and α2 isoforms of AMP-activated protein kinase (AMPK) in
resting and stimulated gastrocnemius muscles from control and trained rats. Values are
means ± SEM, n = 9. *Significantly different from Rest, P < 0.05.
Figure 6. Top: Phospho-acetyl-CoA carboxylase (P-ACC) immunoblot quantification
in resting and stimulated gastrocnemius muscle from control and trained rats. Values
are means ± SEM, n = 10. Bottom: ACC activity in resting and stimulated
gastrocnemius muscle from control and trained rats. Values are means ± SEM, n = 9.
*Significantly different from Rest, P < 0.05. †Significantly different from control at
same stimulation rate.
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Figure 7. Phosphocreatine (PCr) and Glycogen concentrations in resting and
stimulated gastrocnemius muscle from control and trained rats. Values are means ±
SEM, n = 9. *Significantly different from Rest, P < 0.05. †Significantly different from
control at same stimulation rate, P < 0.05.
Figure 8. ATP and Lactate concentrations in resting and stimulated gastrocnemius
muscle from control and trained rats. Values are means ± SEM, n = 9. *Significantly
different from Rest, P < 0.05. †Significantly different from control at same stimulation
rate, P < 0.05.
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